Search

everythinglearnresearchcommunity

for

Search:↓

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Topical cetirizine may help increase hair count in androgenetic alopecia.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Normal skin results from interactions between EGF and the Tabby mutation.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Green tea and gotukola extract mix helps hair grow, with the best results from 5% green tea and 2.5% gotukola.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

BST2 protein and certain T cells increase in early alopecia areata.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.